Gordon, M. A., D'Amato, N. C., Gu, H., Babbs, B., Wulfkuhle, J., Petricoin, E. F., . . . Richer, J. K. (2017). Synergy between androgen receptor antagonism and inhibition of mTOR and HER2 in breast cancer. Mol Cancer Ther.
Chicago Stili AlıntıGordon, Michael A., et al. "Synergy between Androgen Receptor Antagonism and Inhibition of MTOR and HER2 in Breast Cancer." Mol Cancer Ther 2017.
MLA AlıntıGordon, Michael A., et al. "Synergy between Androgen Receptor Antagonism and Inhibition of MTOR and HER2 in Breast Cancer." Mol Cancer Ther 2017.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..